Dengue virus life cycle: viral and host factors modulating infectivity.
Dengue virus (DENV 1-4) represents a major emerging arthropod-borne pathogen. All four DENV serotypes are prevalent in the (sub) tropical regions of the world and infect 50-100 million individuals annually. Whereas the majority of DENV infections proceed asymptomatically or result in self-limited dengue fever, an increasing number of patients present more severe manifestations, such as dengue hemorrhagic fever and dengue shock syndrome. In this review we will give an overview of the infectious life cycle of DENV and will discuss the viral and host factors that are important in controlling DENV infection.
Rodenhuis-Zybert
Izabela A
IA
Molecular Virology Section, Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
Wilschut
Jan
J
Smit
Jolanda M
JM
D000818:Animals; D000917:Antibody Formation; D003713:Dendritic Cells / Q000821:virology; D003715:Dengue / Q000276:immunology / Q000503:physiopathology; D003716:Dengue Virus / Q000145:classification / Q000254:growth & development* / Q000472:pathogenicity / Q000502:physiology; D019281:Dimerization; D005416:Flavivirus / Q000254:growth & development / Q000472:pathogenicity; D006031:Glycosylation; D006801:Humans; D008018:Life Cycle Stages; D008264:Macrophages / Q000821:virology; D008958:Models, Molecular; D009000:Monocytes / Q000821:virology; D009500:Neutralization Tests; D012703:Serotyping; D019595:Severe Dengue / Q000503:physiopathology; D012867:Skin / Q000821:virology; D014764:Viral Proteins / Q000737:chemistry / Q000378:metabolism; D014774:Virulence; D014779:Virus Replication
D014764:Viral Proteins